KPP Advisory Services LLC Has $1.76 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

KPP Advisory Services LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,470 shares of the healthcare conglomerate’s stock after selling 32 shares during the quarter. KPP Advisory Services LLC’s holdings in UnitedHealth Group were worth $1,755,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. M&T Bank Corp raised its stake in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC raised its stake in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. raised its stake in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares in the last quarter. Parsifal Capital Management LP acquired a new position in UnitedHealth Group during the third quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC raised its stake in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on UNH shares. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Bank of America reduced their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $542.30 on Monday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock’s 50 day moving average is $536.17 and its 200-day moving average is $565.26. The firm has a market capitalization of $499.07 billion, a price-to-earnings ratio of 34.99, a PEG ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.